Ex Vivo News and Research

RSS
Positive preliminary data from Fate Therapeutics FT1050 Phase 1b trial in patients with life-threatening conditions

Positive preliminary data from Fate Therapeutics FT1050 Phase 1b trial in patients with life-threatening conditions

Cell Medica enters EBV-associated cancer research collaboration with CAGT and Baylor College of Medicine

Cell Medica enters EBV-associated cancer research collaboration with CAGT and Baylor College of Medicine

Generex, Antigen Express and RXi report positive research data from active immunotherapy collaboration

Generex, Antigen Express and RXi report positive research data from active immunotherapy collaboration

Omeros receives exclusive license for new series of antifibrinolytic agents

Omeros receives exclusive license for new series of antifibrinolytic agents

John Theurer Cancer Center presents research findings at ASH meeting

John Theurer Cancer Center presents research findings at ASH meeting

Arteriocyte launches Stem Cell Expansion System for research use

Arteriocyte launches Stem Cell Expansion System for research use

miRagen and t2cure enter licensing agreement for microRNA 92 technology

miRagen and t2cure enter licensing agreement for microRNA 92 technology

Cascade reaffirms position on non-invasive detection of melanoma by SkinSpect device

Cascade reaffirms position on non-invasive detection of melanoma by SkinSpect device

MRL announces acquisition of world's largest cryo-preserved human cancer tissue bank

MRL announces acquisition of world's largest cryo-preserved human cancer tissue bank

POZEN presents PA32540 Phase 1 study results for cardiovascular disease at AHA Session

POZEN presents PA32540 Phase 1 study results for cardiovascular disease at AHA Session

NexBio presents Fludase data for Influenza-Like Illness at ACAAI 2010

NexBio presents Fludase data for Influenza-Like Illness at ACAAI 2010

Mesoblast broadens cancer indications for bone marrow transplant product

Mesoblast broadens cancer indications for bone marrow transplant product

Aeras Global receives FDA grant to develop biomarkers for TB vaccine

Aeras Global receives FDA grant to develop biomarkers for TB vaccine

Echo commences development of new transdermal biosensor for continuous lactate monitoring

Echo commences development of new transdermal biosensor for continuous lactate monitoring

Scientist develops nano-methods to destroy tumors with fewer side effects

Scientist develops nano-methods to destroy tumors with fewer side effects

Phase II data on Genetic Immunity's DermaVir vaccine to be presented at XVIII International AIDS Conference

Phase II data on Genetic Immunity's DermaVir vaccine to be presented at XVIII International AIDS Conference

Ethicon launches OMNEX Surgical synthetic sealant

Ethicon launches OMNEX Surgical synthetic sealant

Gamida Cell-Teva Joint Venture's StemEx program receives FDA Fast Track Designation

Gamida Cell-Teva Joint Venture's StemEx program receives FDA Fast Track Designation

Life Technologies announces product launches in concert with ISSCR 8th Annual Meeting

Life Technologies announces product launches in concert with ISSCR 8th Annual Meeting

Oncodesign announces technology license agreement with Janssen Pharmaceutica

Oncodesign announces technology license agreement with Janssen Pharmaceutica